Skip to main content
thisisengineering-raeng-qI7USKbZY_A-unsplash
Bladder cancer is relatively common cancer in the UK, with over 10,000 patients diagnosed each year in the UK and approximately 40-50,000 patients living with the disease at any one time.

A new research centre which aims to overcome barriers for a common, but often overlooked cancer has opened at the University of Birmingham with a virtual launch event this week.

Bladder cancer is relatively common cancer in the UK, with over 10,000 patients diagnosed each year in the UK and approximately 40-50,000 patients living with the disease at any one time. Despite this, the disease is subject to a disproportionately small amount of research funding in comparison to other cancers and as such, bladder cancer patients have not benefitted from many of the advances seen in other areas of cancer research.

Bringing together a multi-disciplinary team from the University’s Institute of Cancer and Genomic Sciences, School of Biosciences, and the School of Engineering, the Bladder Cancer Research Centre (BCRC) will build upon the work of the existing Bladder Cancer Research Group to translate biomedical science into healthcare benefits for bladder cancer patients. The dedicated centre has been funded through a combination of University investment and philanthropic donations, which to date, total £1 million.

For media enquiries please contact Sophie Belcher, Communications Manager, University of Birmingham, on +44 7815607157. Alternatively, contact the Press Office out of hours on +44 (0)7789 921165.